SCHEMBL30607297

CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 10)

	gene	UniProt	supporting neighbours	confidence
▸	VIPR2	P41587	7/20	0.60

▸	VIPR1	P32241	5/20	0.59

▸	CALCR	P30988	3/20	0.58

▸	GLP1R	P43220	5/20	0.57

▸	CCKBR	P32239	1/20	0.57

▸	CRHR1	P34998	1/20	0.57

▸	CRHR2	Q13324	1/20	0.57

▸	GCGR	P47871	1/20	0.56

▸	GIPR	P48546	1/20	0.56

▸	PTH1R	Q03431	1/20	0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30176430	0.96	VIPR2 (0.57)	VIPR2VIPR1CALCRGLP1RCCKBR
SCHEMBL31182784	0.92	VIPR1 (0.62)	VIPR2VIPR1CALCRGLP1RCCKBR
Aviptadil SCHEMBL30969141	0.90	VIPR1 (0.72)	VIPR2VIPR1CALCRGLP1RCCKBR
Vasoactive Intestinal Peptide SCHEMBL3041046	0.90	VIPR1 (0.72)	VIPR2VIPR1CALCRGLP1RCCKBR
SCHEMBL29528965	0.90	VIPR2 (0.62)	VIPR2VIPR1CALCRGLP1RCCKBR
SCHEMBL31332028	0.90	VIPR2 (0.66)	VIPR2VIPR1CALCRGLP1RCCKBR
SCHEMBL30495831	0.89	VIPR2 (0.57)	VIPR2VIPR1CALCRGLP1RCCKBR
SCHEMBL31331832	0.89	VIPR1 (0.68)	VIPR2VIPR1CALCRGLP1RCCKBR
SCHEMBL29854442	0.88	VIPR2 (0.67)	VIPR2VIPR1GLP1R
SCHEMBL29649215	0.88	CALCR (0.64)	VIPR2VIPR1CALCRGLP1RCCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-12383505-B2	Nanoparticle for the remodeling of cancer-associated fibroblasts	UNIVERSITY OF SOUTH CAROLINA (US)	2025-08-12	—	—	US	disclosed
US-20230310331-A1	NANOPARTICLE FOR THE REMODELING OF CANCER-ASSOCIATED FIBROBLASTS	UNIVERSITY OF SOUTH CAROLINA (US)	2023-10-05	—	—	US	disclosed